Salesforce (NYSE: CRM) delivered the quarter its investors had waited more than a year to see, and the stock responded with one of its sharpest rallies in memory. Shares jumped about 20% to around $247 after the company reported second-quarter results that showed its AI products finally scaling into real revenue. The durable reason for the move is Agentforce. The eye-catching profit line is something else, and the two should not be confused.
Salesforce surged roughly 20% to about $247 after its Q2 report, recovering from a slump that had left the stock down for the year. Source: TradingViewSalesforce Q2 Report and Why the CRM Stock Jumped
Revenue was $11.3 billion, up 11% from a year earlier and just ahead of consensus, with subscription and support revenue of $10.8 billion. The number Wall Street cares about most, current remaining performance obligations, or the contracted revenue Salesforce expects to book over the next year, reached $33.5 billion, up 14% and above the roughly $33.2 billion analysts expected. Free cash flow jumped 81% to $1.1 billion, well above the $643 million consensus, and Salesforce raised its full-year revenue outlook. Non-GAAP operating margin held at 34.1%.
For a stock that went into the print down about 6.5% year-to-date, still recovering from a long slump, that combination was enough to trigger a violent re-rating. But the report also carried a profit figure that looked far better than the business underneath it.
Investor Takeaway
The 20% move is about the operating reacceleration, not the headline profit. cRPO growth of 14% and free cash flow up 81% are the signals that Salesforce’s AI push is converting into contracted revenue, which is what the market had been waiting to confirm.
The Agentforce Numbers That Re-Rated the Stock
Here is what actually moved the stock: Agentforce annual recurring revenue passed $1.5 billion, up 240% from a year earlier, and combined with Data 360 the figure reached nearly $3.9 billion, up more than 210%. Salesforce said its AI and data ARR is about to cross $4 billion. Usage backed the revenue: customers ran 3.2 billion Agentic Work Units in the quarter, up 97% sequentially, and Slack posted its fastest new-order growth since Salesforce acquired it. Washington said new-order volume hit a four-year high, which is the demand signal that matters most.
The report landed alongside Claudeforce, an expanded partnership that embeds Anthropic’s Claude model into Agentforce and Slack, in pilot now and heading to open beta in September. This is the same application-layer bet Salesforce has been making against the frontier AI labs racing to build their own custom chips and models: CEO Marc Benioff told analysts that customers are not asking about model politics; they want business applications, and that the highest value sits where Salesforce combines data, workflow, and governance with AI. After a year of skepticism about whether Agentforce would ever monetize, these numbers are the answer, and they are why the stock re-rated.
The $2.6 Billion Gain That Flatters the Beat
Salesforce reported non-GAAP earnings of $5.90 a share, up 103%, and GAAP earnings of $4.29, up 119%, against revenue that grew only 11%. That gap is not operations. The company booked a $2.6 billion gain on its strategic-investment portfolio, tied in part to its stake in Anthropic, which was marked up after Anthropic’s May funding round valued the AI lab at $965 billion. A year earlier, that same gain was just $6 million.
Because that gain sits inside the non-GAAP figure, it flatters both earnings lines. Back out the disclosed $2.6 billion, worth roughly $2.5 a share, and underlying operating EPS lands near $3.40, only modestly above the roughly $3.27 analysts had penciled in. EBC Financial Group’s analysis puts the same split at about $2.53 a share of gain and $3.37 of operating earnings, which shrinks an apparent 80% beat to roughly 3%.
Specifically, Salesforce does not disclose how much of the $2.6 billion came from Anthropic specifically, so the honest description is a strategic investment gain tied in part to Anthropic, not a clean “Anthropic gain.” The same distortion runs through the guidance, where the full-year non-GAAP EPS outlook was lifted to $16.67 from $14.06, a jump that is mostly the one-time gain rather than stronger operations.
Only about $3.37 of Salesforce’s $5.90 non-GAAP EPS came from operations, barely above the analyst estimate. The rest was a one-time strategic investment gain tied in part to its Anthropic stake. Source: Salesforce Q2 FY27 release; ex-gain split per EBC Financial Group · Chart: FinanceFeedsWhat Comes Next
Salesforce lifted full-year revenue by $200 million to a $46.1 billion to $46.4 billion range, but the raise is modest and mostly acquisitions: about $100 million organic, $200 million from the pending Contentful and Fin deals closing this quarter, and a $100 million currency headwind. The cleaner tell is the third-quarter guide of $3.42 to $3.44 in non-GAAP EPS, which lands right around this quarter’s ex-gain operating run rate, confirming that roughly $3.40 is the real earnings power, not $5.90.
Enterprise-software stocks led the tape, with the software ETF up about 3% and ServiceNow and Adobe rising in sympathy, while the broad Nasdaq barely moved, a sign the strength was software-specific rather than a market-wide risk-on that lifted chipmakers like Nvidia.
The next checkpoints are the September 16 investor day at Dreamforce and whether that second-half organic reacceleration shows up. One forward risk worth naming: the investment gains that flattered this quarter ride on Anthropic’s valuation, which is tied to the same AI-lab funding cycle now moving toward public markets. If that cycle cools, the paper gains reverse as quickly as it appeared.
Investor Takeaway
The durable variable is second-half organic revenue reacceleration and cRPO holding near 14%, since that is what the Agentforce ramp has to prove now that the market has priced the re-rating.